Metagenomi Therapeutics, Inc. (MGX) stock
Close on Nov 13, 2026Market cap $26.13MP/E –Yield –
Metagenomi Therapeutics statistics
63 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 4, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.28
- 2.22
Share statisticsIndustry
- Shares Change (YoY)
- 1.11%
- 10.8%
- Shares Change (QoQ)
- 0.08%
- 0.50%
- Float
- 34M
- 49M
- Shares Held by Insiders
- 10.4%
- 11.7%
- Shares Held by Institutions
- 16.6%
- 56.4%
Short sellingIndustry
- Short Interest
- 1M
- –
- Short Interest Change
- 2.88%
- -0.80%
- Short % of Float
- 3.93%
- 9.01%
- Short % of Shares Outstanding
- 3.52%
- 6.30%
- Days to Cover
- 11.13
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $1.87
- –
- 52-Week Low
- $0.60
- –
- 20-Day Moving Average
- $0.77
- –
- 50-Day Moving Average
- $0.95
- –
- 200-Day Moving Average
- $1.25
- –
- Average True Range (14)
- $0.08
- –
- Price Change (1 Week)
- -2.50%
- -1.15%
- Price Change (1 Month)
- -18.2%
- -4.87%
- Price Change (3 Months)
- -43.3%
- -21.0%
- Price Change (6 Months)
- -47.2%
- -20.6%
- Price Change (YTD)
- -57.3%
- -23.6%
- Price Change (1 Year)
- -62.8%
- -22.4%
- Average Volume (10 Days)
- 203,247
- –
- Average Volume (20 Days)
- 160,299
- –
- Average Volume (90 Days)
- 162,885
- –
- Relative Volume
- 0.73
- 0.70
- Relative Strength Index (14)
- 33.3
- 43.4
- Volatility (1 Year)
- 53.3%
- 80.1%
- Beta (5 Years)
- 1.28
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -69.4%
- -49.9%
- Return on Assets (ROA)
- -46.5%
- -40.6%
- Return on Capital Employed (ROCE)
- -79.9%
- -37.9%
Financial positionIndustry
- Current Ratio
- 3.43
- 3.30
- Quick Ratio
- 3.14
- 2.39
EfficiencyIndustry
- Profits Per Employee
- -$791.56K
- -$689.41K
- Employee Count
- 119
- 74
- WACC
- 11.5%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$94.15M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $101.70M
- $17.76M
- Net Cash Per Share
- $2.69
- $0.80
- Equity (Book Value)
- $93.19M
- $53.89M
- Book Value Per Share
- $2.47
- $1.50
- Tangible Book Value
- $93.19M
- $27.13M
- Working Capital
- $78.52M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$214.00K
- -$1.00M
- FCF Per Share
- -$2.21
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -360.5%
- -21.8%
- FCF Yield
- -319.7%
- -9.44%
Taxes and interestIndustry
- Income Tax
- $44.00K
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- -4.66
- 0.23
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | MGX | S&P 500 | Difference | MGX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -24.6% | -3.0% | −21.6 pts | ||
| 3 months | -43.8% | -2.8% | −41.0 pts | ||
| Year to date | -57.3% | +11.5% | −68.8 pts | ||
| 1 year | -59.3% | +13.5% | −72.8 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
1M MGX shares were sold short on Oct 30, 2026, up 2.9% from the previous report, or 3.93% of the shares available to trade. At recent volumes it would take 11.1 days to buy them back. Over the last 20 sessions, 32.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 1,329,414 | +2.9% | 119,432 | 11.1 |
| Oct 15, 2026 | 1,292,216 | +1.6% | 206,462 | 6.3 |
| Sep 30, 2026 | 1,271,863 | -11.1% | 120,626 | 10.5 |
| Sep 15, 2026 | 1,430,434 | -0.4% | 195,696 | 7.3 |
| Aug 31, 2026 | 1,435,524 | -1.2% | 135,848 | 10.6 |
| Aug 14, 2026 | 1,453,190 | -2.7% | 132,363 | 11.0 |
| Jul 31, 2026 | 1,493,337 | -3.2% | 148,142 | 10.1 |
| Jul 15, 2026 | 1,543,288 | -8.4% | 237,848 | 6.5 |
| Jun 30, 2026 | 1,684,034 | -4.1% | 144,636 | 11.6 |
| Jun 15, 2026 | 1,755,888 | -4.1% | 153,608 | 11.4 |
| May 29, 2026 | 1,831,424 | +1.3% | 198,963 | 9.2 |
| May 15, 2026 | 1,807,425 | +1.1% | 179,465 | 10.1 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?